Articles · Transfer Pricing
How to compute RAB shares, handle Altera stock-based compensation in IDC pools, and value a Platform Contribution Transaction under the Income Method.
Treas. Reg. § 1.482-7 governs Cost Sharing Arrangements (CSAs) through two tightly coupled cash flows: annual Cost Sharing Transactions (CSTs) allocated by Reasonably Anticipated Benefits (RAB) shares, and Platform Contribution Transactions (PCTs) compensating the transferor of pre-existing intellectual property.
On January 1, 2026, VIT-US (Americas territory) and VIT-Ireland (EMEA/APAC territory) enter a qualified CSA to co-develop GridPulse 3.0. Discounting each participant's reasonably anticipated operating income at 11.00% WACC yields present values of $420.00M for VIT-US (60.00% RAB share) and $280.00M for VIT-Ireland (40.00% RAB share) out of $700.00M total.
In FY2026, VIT-US incurs $40.00M in cash R&D plus $6.00M in R&D Stock-Based Compensation (SBC), while VIT-Ireland incurs $14.00M. Under Treas. Reg. § 1.482-7(d)(3), upheld by the Ninth Circuit in Altera Corp. v. Commissioner, SBC must be included in the IDC pool ($60.00M total IDCs). VIT-Ireland's 40.00% required share is $24.00M, resulting in a $10.00M CST balancing payment to VIT-US. Improperly excluding the $6.00M SBC would reduce the CST to $7.60M, creating a $2.40M IRS audit adjustment exposure.
Because VIT-US contributes pre-existing GridPulse 2.0 platform IP to the CSA, VIT-Ireland must pay an arm's-length PCT Buy-In. Applying the Income Method DCF at a 12.50% pre-tax IP discount rate across five years of decaying legacy IP cash flows ($32.00M, $29.00M, $25.00M, $20.00M, $14.00M) produces a lump-sum PCT Buy-In NPV of $89.17M. Dividing that NPV by the $628.40M present value of five-year EMEA/APAC sales yields an equivalent flat contingent royalty of 14.19%.
| CSA / PCT Metric | VIT-US | VIT-Ireland | Total / Result |
|---|---|---|---|
| PV of Reasonably Anticipated Benefits | $420.00M | $280.00M | $700.00M |
| RAB Share (%) | 60.00% | 40.00% | 100.00% |
| FY2026 IDCs Incurred (Incl. $6.00M SBC) | $46.00M | $14.00M | $60.00M |
| FY2026 CST Balancing Payment | Receives $10.00M | Pays $10.00M | $0.00M Net |
| PCT Buy-In Lump-Sum NPV (@ 12.50%) | Receives $89.17M | Pays $89.17M | 14.19% Equiv. Royalty |
Even a well-modeled PCT Buy-In remains subject to Treas. Reg. § 1.482-7(i)(6) periodic adjustments if the Actually Experienced Return Ratio (AERR) falls outside the 0.667 to 1.500 Periodic Return Ratio Range (PRRR). Tax directors structuring outbound IP transfers should also coordinate CSA formation with IRC Section 351/367(d) rules (see The Section 351 Handbook) and intercompany debt limits (see The Section 385 Handbook and The UK Corporate Interest Restriction Handbook).
Every table in this article is reproduced with live formulas in the free Section 482 Transfer Pricing Calculator, companion to The Section 482 Transfer Pricing Handbook.